Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 192

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 192
---
 research or reports, about us, our business or our market, or if they change
their recommendations regarding our stock adversely, our stock price and trading volume could decline.

The trading market for our common stock will be
influenced, in part, by the research and reports that industry or financial research analysts publish about us and our business. We do
not have any control over these analysts. If only a few securities or industry analysts commence coverage of our company, the trading
price for our stock would likely be negatively affected and there can be no assurance that analysts will provide favorable coverage.
If securities or industry analysts who initiate coverage downgrade our stock or publish inaccurate or unfavorable research about our
business or our market, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail
to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and any trading volume to
decline.

79

Having availed ourselves of scaled disclosure available to smaller
reporting companies, we cannot be certain if such reduced disclosure will make our common stock less attractive to investors.

Under Section 12b-2 of the Exchange Act, a “smaller
reporting company” is a company that is not an investment company, an asset backed issuer, or a majority-owned subsidiary of a
parent company. Effective September 10, 2018, the definition of a “smaller reporting company” was amended to include companies
with a public float of less than $250 million as of the last business day of its most recently completed second fiscal quarter or, if
such public float is less than $700 million, had annual revenues of less than $100 million during the most recently completed fiscal
year. Smaller reporting companies are permitted to provide simplified executive compensation disclosure in their filings; they are exempt
from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that independent registered public accounting firms provide
an attestation report on the effectiveness of internal controls over financial reporting; and they have certain other decreased disclosure
obligations in their SEC filings, including, among other things, only being required to provide two years of audited financial statements
in annual reports. As calculated as of December 31, 2024, we qualified as a smaller reporting company. For as long as we continue to
be a smaller reporting company, we expect that we will take advantage of the reduced disclosure obligations available to us as a result
of